Product managers & owners
Product intent, clinical value, prioritisation and decision-making within a regulated development system.
Guide details →1 PDF · 23 August 2026
Executives & commercial leaders
Decisions, exposure, resources, readiness and business consequences.
Downloadable field guides
Guidance written for your role
Quality & regulatory teams
Two complementary guides covering quality assurance, regulatory strategy, evidence, submissions and lifecycle governance.
Guide details →2 PDFs · 23 August 2026
Risk managers
ISO 14971-centred risk management connected to engineering decisions, evidence and lifecycle governance.
Guide details →1 PDF · 23 August 2026
C-Suite & leadership
Executive decisions, governance, resources, exposure and evidence across a regulated product lifecycle.
Guide details →1 PDF · 23 August 2026
Articles
Related practical guidance
AI! AI! Oh?
A playful but serious reflection on AI as assistant, reviewer and decision-maker—and why fluent answers still need evidence, judgement and accountability.
AI has accelerated medical-device development—but not manufacturer responsibility
AI changes the speed and economics of medical-device development, but it does not remove the need for product definition, objective evidence, competent review or manufacturer accountability.
You outsourced the development—not the accountability
Why outsourcing medical-device development increases the need for intelligent manufacturer oversight—and what must be controlled before an audit or submission exposes the gaps.
From IV to subcutaneous to oral: is this the natural evolution of a medicine?
Does treatment naturally progress from infusion to injection and finally to a tablet—or can digitally supported subcutaneous delivery be the better destination?
Who is responsible for medical-device development? From startup founder to corporate leadership
How the responsibilities of startup founders, SME management and corporate leaders differ—and why qualified external advice is most valuable before major development commitments are made.
Can an unregistered digital health technology be used in a clinical trial?
Why absence of commercial registration does not automatically prevent a digital health technology from being used in a clinical trial—and the questions sponsors should ask instead.
The practical guide to developing a medical device
An end-to-end view of medical-device development, from intended purpose and user needs through verification, validation, transfer and maintenance.
Design controls: from user need to objective evidence
How user needs, requirements, design outputs, risk controls, verification and validation form a coherent evidence chain.
Why an FMEA is not a complete product risk analysis
Understand where FMEA helps, what it misses and how to integrate it into a complete medical-device risk-management process.
IEC 62304 and the medical-device software lifecycle
A practical introduction to IEC 62304, software safety classification and the evidence created across development and maintenance.
Medical-device cybersecurity: an integrated lifecycle approach
How to integrate cybersecurity governance and evidence across the complete medical-device lifecycle.
Verification and validation: what is the difference?
A clear explanation of verification, validation and how both connect to user needs, design inputs and objective evidence.
Building an audit-ready design history file
What makes development evidence coherent, reviewable and defensible before an audit or submission.